vs
Cambium Networks Corp（CMBM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Cambium Networks Corp的1.7倍（$69.8M vs $40.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -17.9%，领先402.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -23.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -27.2%）
坎布里姆网络公司是美国的无线通信设备制造商，主营企业WiFi、网络交换设备、物联网相关产品，以及面向企业的固定无线宽带、WiFi接入产品。该公司于2011年10月从摩托罗拉分拆，目前在纳斯达克上市。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CMBM vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$40.3M
营收增速更快
RIGL
高出44.4%
-23.2%
净利率更高
RIGL
高出402.0%
-17.9%
两年增速更快
RIGL
近两年复合增速
-27.2%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.3M | $69.8M |
| 净利润 | $-7.2M | $268.1M |
| 毛利率 | 36.6% | 91.5% |
| 营业利润率 | -28.4% | 33.2% |
| 净利率 | -17.9% | 384.0% |
| 营收同比 | -23.2% | 21.2% |
| 净利润同比 | 71.0% | 1769.2% |
| 每股收益（稀释后） | $-0.26 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMBMRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | — | $69.5M | ||
| Q2 25 | — | $101.7M | ||
| Q1 25 | — | $53.3M | ||
| Q4 24 | $40.3M | $57.6M | ||
| Q3 24 | $44.7M | $55.3M | ||
| Q2 24 | $45.2M | $36.8M | ||
| Q1 24 | $47.1M | $29.5M |
净利润CMBMRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | — | $27.9M | ||
| Q2 25 | — | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $-7.2M | $14.3M | ||
| Q3 24 | $-34.5M | $12.4M | ||
| Q2 24 | $-14.2M | $-1.0M | ||
| Q1 24 | $-18.4M | $-8.2M |
毛利率CMBMRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | 36.6% | 89.9% | ||
| Q3 24 | 43.6% | 85.5% | ||
| Q2 24 | 32.5% | 92.4% | ||
| Q1 24 | 29.8% | 93.1% |
营业利润率CMBMRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | -28.4% | 28.9% | ||
| Q3 24 | -69.6% | 25.4% | ||
| Q2 24 | -27.2% | 1.2% | ||
| Q1 24 | -33.1% | -23.6% |
净利率CMBMRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | — | 40.2% | ||
| Q2 25 | — | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | -17.9% | 24.9% | ||
| Q3 24 | -77.3% | 22.5% | ||
| Q2 24 | -31.5% | -2.8% | ||
| Q1 24 | -39.2% | -27.9% |
每股收益（稀释后）CMBMRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | $-0.26 | $0.82 | ||
| Q3 24 | $-1.22 | $0.70 | ||
| Q2 24 | $-0.51 | $-0.06 | ||
| Q1 24 | $-0.66 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $67.6M | $52.5M |
| 股东权益账面价值 | $-3.2M | $391.5M |
| 总资产 | $173.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CMBMRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务CMBMRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $67.6M | $60.0M | ||
| Q3 24 | $67.6M | $60.0M | ||
| Q2 24 | $68.9M | $60.0M | ||
| Q1 24 | $63.8M | $60.0M |
股东权益CMBMRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | — | $117.6M | ||
| Q2 25 | — | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | $-3.2M | $3.3M | ||
| Q3 24 | $1.9M | $-14.6M | ||
| Q2 24 | $34.1M | $-29.9M | ||
| Q1 24 | $45.0M | $-31.7M |
总资产CMBMRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | — | $242.5M | ||
| Q2 25 | — | $206.7M | ||
| Q1 25 | — | $176.0M | ||
| Q4 24 | $173.7M | $164.0M | ||
| Q3 24 | $194.3M | $139.4M | ||
| Q2 24 | $221.1M | $128.4M | ||
| Q1 24 | $219.8M | $126.5M |
负债/权益比CMBMRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-10.8M | — |
| 自由现金流率自由现金流/营收 | -26.8% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-21.4M | — |
8季度趋势，按日历期对齐
经营现金流CMBMRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | — | $24.0M | ||
| Q2 25 | — | $30.5M | ||
| Q1 25 | — | $-893.0K | ||
| Q4 24 | $-10.4M | $14.5M | ||
| Q3 24 | $8.9M | $21.7M | ||
| Q2 24 | $2.4M | $302.0K | ||
| Q1 24 | $-15.9M | $-5.0M |
自由现金流CMBMRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $87.0K | — | ||
| Q1 24 | $-17.4M | — |
自由现金流率CMBMRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -26.8% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -37.0% | — |
资本支出强度CMBMRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 3.3% | — |
现金转化率CMBMRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
RIGL
暂无分部数据
